MOVEZ Stock Overview
Develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Medacta Group SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 106.20 |
| 52 Week High | CHF 134.40 |
| 52 Week Low | CHF 103.80 |
| Beta | 1.19 |
| 1 Month Change | -4.58% |
| 3 Month Change | -10.76% |
| 1 Year Change | -17.67% |
| 3 Year Change | -26.04% |
| 5 Year Change | n/a |
| Change since IPO | -11.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| MOVEZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.5% | -2.3% | -2.2% |
| 1Y | -17.7% | -10.6% | 2.4% |
Return vs Industry: MOVEZ underperformed the UK Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: MOVEZ underperformed the UK Market which returned 2.4% over the past year.
Price Volatility
| MOVEZ volatility | |
|---|---|
| MOVEZ Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MOVEZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: MOVEZ's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 1,826 | Francesco Siccardi | www.medacta.com |
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Medacta Group SA Fundamentals Summary
| MOVEZ fundamental statistics | |
|---|---|
| Market cap | CHF 2.12b |
| Earnings (TTM) | CHF 52.38m |
| Revenue (TTM) | CHF 507.14m |
40.5x
P/E Ratio4.2x
P/S RatioIs MOVEZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOVEZ income statement (TTM) | |
|---|---|
| Revenue | €544.29m |
| Cost of Revenue | €174.57m |
| Gross Profit | €369.72m |
| Other Expenses | €313.51m |
| Earnings | €56.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.82 |
| Gross Margin | 67.93% |
| Net Profit Margin | 10.33% |
| Debt/Equity Ratio | 54.1% |
How did MOVEZ perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield21%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 06:04 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medacta Group SA is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Christoph Gretler | Credit Suisse |
| David Adlington | J.P. Morgan |